Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Annals of the New York Academy of Sciences
|
July 23, 1999
Metabolic changes in the normal and hypoxic neonatal myocardium
S Abdel-Aleem, J D St Louis, G C Hughes, et al.
Journal of Cardiovascular Pharmacology
|
January 16, 1999
Stimulation of long-chain fatty acid uptake by dipyridamole in isolated myocytes
S Abdel-aleem, N El-Guindy, T I Sallam, et al.
The Journal of Trauma
|
February 24, 1999
The use of a temporary vena caval interruption device in high-risk trauma patients unable to receive standard venous thromboembolism prophylaxis
G C Hughes, T P Smith, S R Eachempati, et al.
Journal of the American College of Cardiology
|
March 26, 1999
Perioperative morbidity and mortality after transmyocardial laser revascularization: incidence and risk factors for adverse events
G C Hughes, K P Landolfo, J E Lowe, et al.
American Heart Journal
|
May 29, 1999
Diagnosis, incidence, and clinical significance of early postoperative ischemia after transmyocardial laser revascularization
G C Hughes, K P Landolfo, J E Lowe, et al.
The Canadian Journal of Cardiology
|
July 20, 1999
Transmyocardial laser revascularization: experimental and clinical results
G C Hughes, S Abdel-aleem, S S Biswas, et al.
Experimental Hematology
|
January 29, 1999
The Fanconi anemia group C gene product modulates apoptotic responses to tumor necrosis factor-alpha and Fas ligand but does not suppress expression of receptors of the tumor necrosis factor receptor superfamily
P S Koh, G C Hughes, G R Faulkner, et al.
Circulation
|
November 24, 1999
Intermediate-term clinical outcome following transmyocardial laser revascularization in patients with refractory angina pectoris
C K Landolfo, K P Landolfo, G C Hughes, et al.
The Annals of Thoracic Surgery
|
July 24, 2001
Is chronically dysfunctional yet viable myocardium distal to a severe coronary stenosis hypoperfused?
G C Hughes, C K Landolfo, B Yin, et al.
HSR Proceedings in Intensive Care & Cardiovascular Anesthesia
|
February 27, 2013
Institutional response to FDA warning on aprotinin and impact on outcomes
M Swaminathan, M Stuart, G C Hughes, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Annals of the New York Academy of Sciences
|
July 23, 1999
Metabolic changes in the normal and hypoxic neonatal myocardium
S Abdel-Aleem, J D St Louis, G C Hughes, et al.
Journal of Cardiovascular Pharmacology
|
January 16, 1999
Stimulation of long-chain fatty acid uptake by dipyridamole in isolated myocytes
S Abdel-aleem, N El-Guindy, T I Sallam, et al.
The Journal of Trauma
|
February 24, 1999
The use of a temporary vena caval interruption device in high-risk trauma patients unable to receive standard venous thromboembolism prophylaxis
G C Hughes, T P Smith, S R Eachempati, et al.
Journal of the American College of Cardiology
|
March 26, 1999
Perioperative morbidity and mortality after transmyocardial laser revascularization: incidence and risk factors for adverse events
G C Hughes, K P Landolfo, J E Lowe, et al.
American Heart Journal
|
May 29, 1999
Diagnosis, incidence, and clinical significance of early postoperative ischemia after transmyocardial laser revascularization
G C Hughes, K P Landolfo, J E Lowe, et al.
The Canadian Journal of Cardiology
|
July 20, 1999
Transmyocardial laser revascularization: experimental and clinical results
G C Hughes, S Abdel-aleem, S S Biswas, et al.
Experimental Hematology
|
January 29, 1999
The Fanconi anemia group C gene product modulates apoptotic responses to tumor necrosis factor-alpha and Fas ligand but does not suppress expression of receptors of the tumor necrosis factor receptor superfamily
P S Koh, G C Hughes, G R Faulkner, et al.
Circulation
|
November 24, 1999
Intermediate-term clinical outcome following transmyocardial laser revascularization in patients with refractory angina pectoris
C K Landolfo, K P Landolfo, G C Hughes, et al.
The Annals of Thoracic Surgery
|
July 24, 2001
Is chronically dysfunctional yet viable myocardium distal to a severe coronary stenosis hypoperfused?
G C Hughes, C K Landolfo, B Yin, et al.
HSR Proceedings in Intensive Care & Cardiovascular Anesthesia
|
February 27, 2013
Institutional response to FDA warning on aprotinin and impact on outcomes
M Swaminathan, M Stuart, G C Hughes, et al.
Page
of 3